Case number 1:23-cv-00470
AbbVie Inc. v. Prinston Pharmaceutical Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 6, 2023 | 7 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Prinston Pharmaceutical Inc. waiver sent on 6/6/2023, answer due 8/7/2023. (Tigan, Jeremy) (Entered: 06/06/2023) (1) |
| Jun 6, 2023 | 8 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Solco Healthcare US, LLC waiver sent on 6/6/2023, answer due 8/7/2023. (Tigan, Jeremy) (Entered: 06/06/2023) (1) |
| Jun 6, 2023 | 9 | WAIVER OF SERVICE returned executed by AbbVie Inc.: For Zhejiang Huahai Pharmaceutical Co., Ltd. waiver sent on 6/6/2023, answer due 8/7/2023. (Tigan, Jeremy) (Entered: 06/06/2023) (1) |
| May 4, 2023 | 6 | MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Roscetti, Danielle A. Duszczyszyn, William B. Raich, Constance P. Lee, Ryan V. McDonnell and Reinaldo Franqui Machin - filed by AbbVie Inc.. (Tigan, Jeremy) (Entered: 05/04/2023) (9) |
| Apr 28, 2023 | 1 | Complaint* (1) |
| Apr 28, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 04/28/2023) (3) |
| Apr 28, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 03/15/2023. Date of Expiration of Patent: 09/01/2036.Thirty Month Stay Deadline: 1/23/2026. (vfm) (Entered: 04/28/2023) (2) |
| Apr 28, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,537,572 B2 ;10,682,351 B2. (vfm) (Entered: 04/28/2023) (1) |
| Apr 28, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (vfm) (Entered: 04/28/2023) (1) |
